The U.S. Food and Drug Administration on ‌Thursday approved Johnson & Johnson's treatment for a type of blood cancer, making ...

Another front opens in the battle between hospitals and drugmakers over the 340B drug discount program Good afternoon, and thanks for checking in with the Health Brief newsletter. Please send any tips ...

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Trump wants to focus on his efforts to lower drug prices, but the TrumpRx website is falling short of his promises.

NYU Langone Health had stopped providing puberty-blocking medication and hormone treatments after the federal government threatened to pull its funding.

The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.

A service tailored to people with workplace-based insurance coverage represents a new way for Lilly to bypass insurers and expand use of its popular obesity shot.

LOS ANGELES, CA - March 04, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has published a ...

With our Phase IIa program underway and defined milestones in front of us, we look forward to engaging with investors and potential partners at BIO.” — Christer Rosén, Chairman and Chief Executive ...

A change in federal grant rules has added new uncertainty about what services might trigger a grant cancellation notice. Employees don’t know what further precautions to take. Administrators are ...

President Donald Trump's administration is expanding its crackdown on state Medicaid programs to New York, launching a fraud probe in the state.

An increasing number of women who use estrogen patches to help deal with perimenopause and menopause symptoms have been ...